Sustained Release Excipients Market Trends, Demand & Growth by 2034

Sustained Release Excipients Market Size and Forecasts (2021–2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Product Type (Gelatin, Polymers, Minerals, Sugars); Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous); Technology (Targeted Delivery, Microencapsulation, Wurster Technique); and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00040800
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
Sustained Release Excipients Market Trends, Demand & Growth by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00040800 Email: sales@theinsightpartners.com

2025 Market Size

US$ 3.26 Bn

Base year value

2034 Forecast

US$ 6.2 Bn

Projected by 2034

CAGR 2026-2034

8.37 %

Growth rate

Addressable Market

US$ 44.80 Bn

(2026-2034)

The Sustained Release Excipients Market size is expected to reach US$ 6.2 Billion by 2034 from US$ 3.26 Billion in 2025. The market is estimated to record a CAGR of 8.37% from 2026 to 2034.

The report is segmented by Product Type (Gelatin, Polymers, Minerals, Sugars, Others). The report further presents analysis based on Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous, Others). Futher, it is segmented based on Technology (Targeted Delivery, Microencapsulation, Wurster Technique, Others). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.

Purpose of the Report

The report Sustained Release Excipients Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Sustained Release Excipients Market Segmentation Product Type

  1. Gelatin
  2. Polymers
  3. Minerals
  4. Sugars

Route of Administration

  1. Oral
  2. Intramuscular
  3. Subcutaneous
  4. Transdermal
  5. Intravenous

Technology

  1. Targeted Delivery
  2. Microencapsulation
  3. Wurster Technique

Market Assessment and Insights

  • Global market for Sustained Release Excipients was valued at US$ 3.26 Billion in 2025
  • Annual market size is expected to reach US$ 6.20 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 44.80 Billion
  • Market is anticipated to register a CAGR of 8.37% during the forecast period
  • The United States represents a key market, supported by Growing Chronic Diseases, Advancements in Pharmaceutical Technology, Patient Preference for Fewer Doses, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Rising Demand for Oral Controlled-Release Medications, Growing Biopharmaceutical Market, Regulatory Approvals are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Evonik Industries, BASF SE, Dow Chemical Company, Ashland Global Holdings Inc., Lonza Group, Merck & Co., Inc., Colorcon, Inc., Mitsubishi Chemical Corporation, JRS Pharma, Wacker Chemie AG, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Sustained Release Excipients Market: Strategic Insights

sustained-release-excipients-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Sustained Release Excipients Market Growth Drivers

  1. Growing Chronic Diseases: The increasing prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, has escalated the need for sustained-release formulations to manage long-term drug delivery.
  2. Advancements in Pharmaceutical Technology: Developments in excipient technology have enhanced the effectiveness of sustained-release formulations, making them more efficient in delivering drugs over extended periods.
  3. Patient Preference for Fewer Doses: Sustained release excipients allow for the formulation of drugs that require fewer doses, improving patient adherence and convenience. This trend is driving demand in the pharmaceutical industry.

Sustained Release Excipients Market Future Trends

  1. Increased Use in Biopharmaceuticals: There is a growing trend of using sustained-release excipients in biologics and biosimilars, particularly in oncology and immunology, as these formulations help improve drug efficacy and patient outcomes.
  2. Customized Drug Delivery Systems: Pharmaceutical companies are increasingly focusing on developing excipients that can provide targeted and controlled drug delivery to specific areas of the body, such as the gut or brain, to improve therapeutic effects.
  3. Sustainability and Biodegradable Excipients: The demand for biodegradable and eco-friendly excipients is rising. Manufacturers are incorporating sustainable materials that reduce environmental impact while maintaining the effectiveness of sustained-release formulations.

Sustained Release Excipients Market Opportunities

  1. Rising Demand for Oral Controlled-Release Medications: With increasing demand for oral dosage forms that offer controlled release, there is a growing opportunity for sustained-release excipient manufacturers to cater to this market.
  2. Growing Biopharmaceutical Market: As the biopharmaceutical industry expands, the need for specialized sustained-release excipients for biologics is expected to increase, creating market opportunities.
  3. Regulatory Approvals: Opportunities exist for excipient manufacturers to collaborate with pharmaceutical companies to meet the evolving regulatory requirements for sustained-release formulations, which are becoming more stringent.

Sustained Release Excipients Market Report Scope

Report Attribute Details
Market size in 2025 US$ 3.26 Billion
Market Size by 2034 US$ 6.2 Billion
Global CAGR (2026 - 2034) 8.37%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product Type
  • Gelatin
  • Polymers
  • Minerals
  • Sugars
By Route of Administration
  • Oral
  • Intramuscular
  • Subcutaneous
  • Transdermal
  • Intravenous
By Technology
  • Targeted Delivery
  • Microencapsulation
  • Wurster Technique
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Evonik Industries
  • BASF SE
  • Dow Chemical Company
  • Ashland Global Holdings Inc.
  • Lonza Group
  • Merck & Co., Inc.
  • Colorcon, Inc.
  • Mitsubishi Chemical Corporation
  • JRS Pharma
  • Wacker Chemie AG

Sustained Release Excipients Market Players Density: Understanding Its Impact on Business Dynamics

The Sustained Release Excipients Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

sustained-release-excipients-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Sustained Release Excipients Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Sustained Release Excipients Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Chronic diseases, technological advancements in drug delivery, and patient preference for fewer doses are key drivers.

These excipients allow for controlled drug release, leading to better disease management with fewer doses, improving patient adherence.

Trends include the rise of biopharmaceuticals, customized drug delivery systems, and the shift toward biodegradable excipients.

Opportunities include catering to oral controlled-release medications, the growing biopharmaceutical sector, and meeting evolving regulatory standards.

Key players include Evonik Industries, BASF, Dow Chemical, and Ashland Global Holdings.

The shift to biodegradable and eco-friendly excipients reduces the environmental footprint while maintaining the functionality of sustained-release formulations.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA